ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 77 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $153,000 | -45.6% | 74,256 | +7.4% | 0.00% | 0.0% |
| Q4 2021 | $281,000 | -10.8% | 69,140 | +13.6% | 0.00% | -50.0% |
| Q3 2021 | $315,000 | +21.6% | 60,848 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $259,000 | -36.5% | 60,848 | -20.9% | 0.00% | -66.7% |
| Q1 2021 | $408,000 | +48.9% | 76,920 | +51.1% | 0.00% | +50.0% |
| Q4 2020 | $274,000 | +122.8% | 50,907 | +77.9% | 0.00% | -33.3% |
| Q1 2019 | $123,000 | -12.8% | 28,621 | +8.7% | 0.00% | -25.0% |
| Q4 2018 | $141,000 | -5.4% | 26,341 | +139.9% | 0.00% | +33.3% |
| Q3 2018 | $149,000 | – | 10,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |